Drugs / Rituximab and Hyaluronidase Human
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03267433 | Nov 2017 → Jan 2027 expected | mantle cell lymphoma | ECOG-ACRIN Cancer Research Group | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rituximab and Hyaluronidase Human | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03267433 ↗ |
| Route | Subcutaneous | “Given SC” NCT03267433 ↗ |